We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · March 09, 2021

Imiquimod 3.75% vs Photodynamic Therapy for Actinic Keratosis of the Scalp

Photodermatology, Photoimmunology & Photomedicine


Additional Info

Photodermatology, Photoimmunology & Photomedicine
Comparative Study of Imiquimod 3.75% vs. Photodynamic Therapy for Actinic Keratosis of the Scalp
Photodermatol Photoimmunol Photomed 2021 Feb 10;[EPub Ahead of Print], C Cortelazzi, G Odorici, E Castagnetti, G Pellacani, S Di Nuzzo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading